260 related articles for article (PubMed ID: 12046112)
1. Prescription drug benefits for seniors and public/private collaboration.
Brekke M
Beginnings; 2002; 22(3):11. PubMed ID: 12046112
[No Abstract] [Full Text] [Related]
2. Drug coverage insurance as a novel element of private health insurance in Poland.
Czerw A; Religioni U
Acta Pol Pharm; 2013; 70(4):763-7. PubMed ID: 23923401
[TBL] [Abstract][Full Text] [Related]
3. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Hurley J; van Doorslaer E
Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
[TBL] [Abstract][Full Text] [Related]
4. Private, individual drug coverage in the current Medicare market.
Boccuti C; Moon M
Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
[No Abstract] [Full Text] [Related]
5. Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
Goldstein WC; Peterson KA
Manag Care Interface; 2002 Jun; 15(6):55-8. PubMed ID: 12087608
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
7. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
8. The Medicare prescription drug benefit.
Ferman JH
Healthc Exec; 2001; 16(4):58-9. PubMed ID: 11434135
[No Abstract] [Full Text] [Related]
9. Medicare at the crossroads: a roundtable discussion on prescription drug coverage.
Bandow D; Cahill J; Carey MA; Neuman P; Allison-Ottey S; Perkins RW; Rother J
Mod Healthc; 2003 Nov; 33(45):suppl 8 p. following 16. PubMed ID: 14666551
[No Abstract] [Full Text] [Related]
10. Debate rages over pharmaceutical coverage for seniors.
Benjamin GC
Physician Exec; 2001; 27(5):86-7. PubMed ID: 12881913
[TBL] [Abstract][Full Text] [Related]
11. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
Sarma S; Basu K; Gupta A
Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
[TBL] [Abstract][Full Text] [Related]
12. Supreme disagreement: the highest court affirms an empty right.
Flood CM; Sullivan T
CMAJ; 2005 Jul; 173(2):142-3. PubMed ID: 15967947
[No Abstract] [Full Text] [Related]
13. The new drug war.
Parloff R
Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
[No Abstract] [Full Text] [Related]
14. [Expert evaluation of private drug prescriptions].
Kreck C; Saller R
Gesundheitswesen; 1995 May; 57(5):258-63. PubMed ID: 7620245
[TBL] [Abstract][Full Text] [Related]
15. Inequity in publicly funded physician care: what is the role of private prescription drug insurance?
Allin S; Hurley J
Health Econ; 2009 Oct; 18(10):1218-32. PubMed ID: 19097042
[TBL] [Abstract][Full Text] [Related]
16. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
17. Prescription drug pricing: the consumer perspective.
Searing A
N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
[No Abstract] [Full Text] [Related]
18. Private medical care comes to Canada.
CMAJ; 2005 Aug; 173(3):225, 227. PubMed ID: 16076799
[No Abstract] [Full Text] [Related]
19. Tensions in private health insurance regulation.
Willcox S
J Law Med; 2003 Feb; 10(3):325-38. PubMed ID: 12650003
[TBL] [Abstract][Full Text] [Related]
20. Public versus private: the medical resident perspective.
Hoyt B
CMAJ; 2005 Oct; 173(8):898-9. PubMed ID: 16217114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
